17
Participants
Start Date
August 31, 2009
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Lenalidomide
Lead-In beginning dose of 5 mg capsules by mouth once a day for 21 days in a row, followed by 7 days of rest (Days 22-28) for a 28 day cycle.
Paclitaxel
50 mg/m\^2 given by vein over 1 hour on Days 1, 8, and 15 of each 28 day cycle.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER